COLA: Evaluation of Chronic Cough

Session recorded on August 4, 2017.

Speaker: Alan Goldsobel, MD

Viewers can earn credit by completing the posttest questions.

Cough is the most common reason for patients to see a physician in the outpatient setting and an extremely common symptom for patients seen by Allergists / Immunologists.  New research has now shown that up to 40% of adults with chronic cough have a cause unrelated to other underlying disease such as rhinitis, asthma, GERD or other conditions.  This is now being called chronic idiopathic cough.  This video recording addresses the therapeutic approaches for treating patients with a hypersensitivity of the cough reflex, and it covers the new pharmacologic agents that are being developed to block the cough hypersensitivity.

Target Audience

Practicing Allergists / Immunologists

Learning Objectives

After viewing this video recording, learners should be able to:

  • Describe common causes of chronic cough
  • Discuss common pitfalls in cough management
  • Describe practical and cost-effective ways to manage chronic cough
  • Accurately order tests used to evaluate patients with chronic cough, and aptly interpret results
Additional information

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity.

Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Alan Goldsobel, MD, Speaker
Principal Investigator, Contracted Research: Merck (Afferent), Nerre

Jay Portnoy, MD, Planner
Speaker, Honorarium: Thermofisher, Boehringer Ingelheim

The following have no financial relationships to disclose:

Paul Dowling, MD, Planner

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
Course expires: 

Alan Goldsobel, MD
Allergy and Asthma Associates of Northern California
Adjunct Clinical Professor Pediatrics, Stanford University Medical Center
Clinical Professor Medicine, UCSF

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
There is no commercial support for this activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Accreditation Period

Course opens: 
Course expires: 


Please login or create an account to take this course.